Skip to main content

Table 1 Baseline and clinical characteristics of the study population analyzed using Pearson's chi-square test

From: Evaluation after implementation of chemical bowel preparation for surgical site infections in elective colorectal cancer surgery and role of antimicrobial stewardship pharmacist: Retrospective cohort study

Characteristics, n (%)

Patient undergoing elective colorectal surgery (N = 414)

p

SSI ( +) (N = 41)

SSI (-) (N = 373)

Female sex

13 (31.7%)

191 (51.2%)

0.018

Age ≥ 60

35 (85.4%)

322 (77.8%)

0.865

Diabetes

10 (24.4%)

64 (17.2%)

0.251

Smoking

11 (26.8%)

51 (13.7%)

0.025

Location

 Colon

31 (75.6%)

269 (72.1%)

0.635

 Rectum

10 (24.4%)

104 (27.9%)

Wound class

 Clean-contaminated

39 (95.1%)

371 (99.5%)

0.007

 Dirty-infected

2 (4.9%)

2 (0.5%)

ASA-PS

 1

1 (2.4%)

38 (10.2%)

0.114

 2

35 (85.4%)

312 (83.7%)

 3

5 (12.2%)

23 (6.2%)

Laparoscopy

26 (63.4%)

316 (84.7%)

 < 0.001

Stoma construction

8 (19.5%)

54 (14.5%)

0.391

Mechanical bowel preparation

30 (73.2%)

267 (71.6%)

0.830

Chemical bowel preparation

9 (2.2%)

158 (38.2%)

0.012

  1. SSI surgical site infection, ASA-PS American Society of Anesthesiologists physical status